Evidence map›Paper›PMID 39699073›Full record

ArticleAnnals of neurology2025

The Utility of Long-Read Sequencing in Diagnosing Early Onset Parkinson's Disease.

Kensuke Daida, Hiroyo Yoshino, Laksh Malik, Breeana Baker, Mayu Ishiguro, Rylee Genner, Kimberly Paquette, Yuanzhe Li, Kenya Nishioka, Satoshi Masuzugawa and 7 more

Abstract read
In one paragraph

Article in Annals of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Integrating Long-Read Nanopore Sequencing for Precision Resolution of Genomic Variants in Dystonia.Movement disorders : official journal of the Movement Disorder Society · 2026
    Article
  4. Article
  5. Compound Heterozygous Structural Variants in Cases with Unsolved PRKN-Associated Parkinson's Disease.Movement disorders : official journal of the Movement Disorder Society · 2025
    Article
  6. Article
  7. Screening of Hidden Pathogenic Structural Variants in PRKN.Movement disorders : official journal of the Movement Disorder Society · 2025
    Article
  8. Article
  9. Exploration of Neurodegenerative Diseases Using Long-Read Sequencing and Optical Genome Mapping Technologies.Movement disorders : official journal of the Movement Disorder Society · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Kensuke DaidaIntegrative Neurogenomics Unit, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0002-9177-9587
Hiroyo YoshinoResearch Institute for Diseases of Old Age, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
Laksh MalikCenter for Alzheimer's and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
Breeana BakerCenter for Alzheimer's and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
Mayu IshiguroDepartment of Neurology, Faculty of Medicine, Juntendo University, Tokyo, Japan.
Rylee GennerCenter for Alzheimer's and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
Kimberly PaquetteCenter for Alzheimer's and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
Yuanzhe LiDepartment of Neurology, Faculty of Medicine, Juntendo University, Tokyo, Japan.
Kenya NishiokaDepartment of Neurology, Juntendo Tokyo Koto Geriatric Medical Center, Tokyo, Japan.
Satoshi MasuzugawaMasuzugawa Neurology Clinic, Suzuka, Japan.
Makito HiranoDepartment of Neurology, Kindai University Faculty of Medicine, Osaka, Japan.
Kenta TakahashiDivision of Neurology and Gerontology, Department of Internal Medicine, School of Medicine, Iwate Medical University, Morioka, Japan.
Mikhail KolmogorovCenter for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Kimberley J BillingsleyMolecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0002-8003-4029
Manabu FunayamaDepartment of Neurology, Faculty of Medicine, Juntendo University, Tokyo, Japan.
Cornelis BlauwendraatIntegrative Neurogenomics Unit, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0001-9358-8111
Nobutaka HattoriDepartment of Neurology, Faculty of Medicine, Juntendo University, Tokyo, Japan.

Funding

Long-read DNA sequencing of Alzheimers Disease and Related Dementias casesZIAAG000538 · NIA · NATIONAL INSTITUTE ON AGING · PI COOKSON, MARK · 2020 to 2025
$39.6M
Long-read DNA sequencing of Parkinson's disease and related disordersZIAAG000542 · NIA · NATIONAL INSTITUTE ON AGING · PI BLAUWENDRAAT, CORNELIS · 2023 to 2023
$270k
Intramural NIH HHS ZIA AG000538Intramural NIH HHS ZIA AG000542Japan Agency for Medical Research and Development 23bm1423015h0001Japan Agency for Medical Research and Development 24ek0109677h0002Japan Society for the Promotion of Science 20K07893Japan Society for the Promotion of Science 21H04820Japan Society for the Promotion of Science 21K07283Japan Society for the Promotion of Science 22K07542Japan Society for the Promotion of Science 23K06958Japan Society for the Promotion of Science 24H00068Japan Society for the Promotion of Science 24K02372Juntendo UniversityMoonshot Research and Development Program JPMJMS2024Promotion and Mutual Aid Corporation for Private Schools of JapanThe Intramural Research Program of the NIH, National Institute on Aging (NIA), National Institutes of Health 1ZIAAG000538-04The Intramural Research Program of the NIH, National Institute on Aging (NIA), National Institutes of Health 1ZIAAG000542-01
6 · The paper itself

Abstract

objectiveVariants in PRKN and PINK1 are the leading cause of early-onset autosomal recessive Parkinson's disease, yet many cases remain genetically unresolved. We previously identified a 7 megabases complex structural variant in a pair of monozygotic twins using Oxford Nanopore Technologies (ONT) long-read sequencing. This study aims to determine if ONT long-read sequencing can detect a second variant in other unresolved early-onset Parkinson's disease (EOPD) cases with 1 heterozygous PRKN or PINK1 variant.

methodsONT long-read sequencing was performed on EOPD patients with 1 reported PRKN/PINK1 pathogenic variant, with onset age under 50. Positive controls included EOPD patients with 2 known PRKN pathogenic variants. Initial testing involved short-read targeted panel sequencing for single nucleotide variants and multiplex ligation-dependent probe amplification for copy number variants.

resultsA total of 47 patients were studied (PRKN "one-variant," n = 23; PINK1 "one-variant," n = 12; PRKN "two-variants," n = 12). ONT long-read sequencing identified a second pathogenic variant in 26% of PRKN "one-variant" patients (6/23), but none in PINK1 "one-variant" patients (0/12). Detected variants included 1 complex inversion, 2 structural variant overlaps, and 3 duplications. In the PRKN "two-variants" group, both variants were identified in all patients (100%, 12/12).

interpretationONT long-read sequencing effectively identifies pathogenic structural variants in the PRKN locus missed by conventional methods. It should be considered for unresolved EOPD cases when a second variant is not detected through conventional approaches. ANN NEUROL 2025;97:753-765.

Indexed as

Parkinson DiseaseProtein KinasesUbiquitin-Protein LigasesAdultAge of OnsetDNA Copy Number VariationsFemaleHigh-Throughput Nucleotide SequencingHumansMaleMiddle AgedPTEN-Induced Putative Kinaseparkin proteinProtein KinasesPTEN-Induced Putative KinaseUbiquitin-Protein Ligases

Identifiers

PMID39699073
PMCPMC11889530

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.